Furthermore, we know little about the change in ACE-1 and ACE-2 in relation to early or intermediate disease stages in AD—most neuropathological studies in human brain tissue have focused on end-stage disease (8,11,12,21,22). Here, ACE is linked to Alzheimer disease.